% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Kobold:298424,
      author       = {S. Kobold$^*$},
      title        = {{ROR}ing {CAR} {T} {C}ells in {S}olid and {H}ematologic
                      {C}ancers: {S}ame but {D}ifferent.},
      journal      = {Clinical cancer research},
      volume       = {31},
      number       = {3},
      issn         = {1078-0432},
      address      = {Philadelphia, Pa. [u.a.]},
      publisher    = {AACR},
      reportid     = {DKFZ-2025-00280},
      pages        = {437 - 438},
      year         = {2025},
      note         = {Summary},
      abstract     = {A recent phase I clinical study tested anti-ROR1 chimeric
                      antigen receptor (CAR) T cells in patients with chronic
                      lymphocytic leukemia, non-small cell lung cancer, and
                      triple-negative breast cancer. The product could be safely
                      administered and had activity in chronic lymphocytic
                      leukemia but less so in non-small cell lung cancer and
                      triple-negative breast cancer. See related article by
                      Jaeger-Ruckstuhl et al., p. 503.},
      keywords     = {Humans / Immunotherapy, Adoptive: methods / Receptors,
                      Chimeric Antigen: immunology / Hematologic Neoplasms:
                      therapy / Hematologic Neoplasms: immunology / T-Lymphocytes:
                      immunology / Receptors, Antigen, T-Cell: immunology /
                      Receptors, Antigen, T-Cell: genetics / Receptors, Antigen,
                      T-Cell: metabolism / Leukemia, Lymphocytic, Chronic, B-Cell:
                      immunology / Leukemia, Lymphocytic, Chronic, B-Cell: therapy
                      / Neoplasms: immunology / Neoplasms: therapy / Carcinoma,
                      Non-Small-Cell Lung: immunology / Carcinoma, Non-Small-Cell
                      Lung: therapy / Carcinoma, Non-Small-Cell Lung: pathology /
                      Triple Negative Breast Neoplasms: immunology / Triple
                      Negative Breast Neoplasms: therapy / Triple Negative Breast
                      Neoplasms: pathology / Female / Receptors, Chimeric Antigen
                      (NLM Chemicals) / Receptors, Antigen, T-Cell (NLM
                      Chemicals)},
      cin          = {MU01},
      ddc          = {610},
      cid          = {I:(DE-He78)MU01-20160331},
      pnm          = {899 - ohne Topic (POF4-899)},
      pid          = {G:(DE-HGF)POF4-899},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:39625823},
      pmc          = {pmc:PMC7617067},
      doi          = {10.1158/1078-0432.CCR-24-3688},
      url          = {https://inrepo02.dkfz.de/record/298424},
}